A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.
about
Regulation of Bim in Health and DiseaseUrokinase receptor and resistance to targeted anticancer agentsuPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.Epidermal growth factor receptor targeting and challenges in glioblastoma.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.Current trends in mouse models of glioblastoma.A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients.The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.
P2860
Q26781203-F494185A-06E3-49FF-BF39-92879D54B932Q26797385-AB0C5278-DF9F-487C-B36B-3262DD2302CAQ30249137-E61EA0EB-A554-40A8-A49F-BCE706FCB679Q35721585-A937A8D1-209C-4524-99C7-1BA6FD00C59DQ35828426-61BBF0A7-8E70-4B7F-863A-3D490CA5A417Q36225233-9A0556B5-9298-4642-B49E-DD5C220C1529Q36977684-E6EFA181-F86A-4D4A-815A-438120221BFCQ40116157-A26ED455-8A08-41B7-BEB8-9CC7AE1E960AQ46093038-0EE8123A-B168-4525-8178-56BA47B92779Q47169542-3A762288-84D0-4A8C-B120-628F43E97ADFQ47979201-09EFA0C6-7B79-4048-BAC1-5713B047A014Q48220228-FC2E4940-52CC-4478-8D9B-0CC882222BF5Q48658011-1ACACBDB-4C96-4412-86A8-E7E643FC4EC6Q50201202-28701E4C-98D5-49D6-B759-20B6520761F9
P2860
A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@ast
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@en
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@nl
type
label
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@ast
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@en
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@nl
prefLabel
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@ast
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@en
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@nl
P2093
P2860
P1433
P1476
A urokinase receptor-Bim signa ...... e in mutant EGFR glioblastoma.
@en
P2093
Amy Haseley Thorne
Clark C Chen
Donald Pizzo
Genaro R Villa
German G Gomez
Jill Wykosky
Jingjing Hu
Paul S Mischel
Scott R VandenBerg
Steven L Gonias
P2860
P304
P356
10.1158/0008-5472.CAN-14-2004
P407
P577
2014-11-28T00:00:00Z